|
|
|
|
Vol. 30, Issue 8, 918-923, August 2002
Division of Drug Delivery and Disposition, School of Pharmacy,
University of North Carolina, Chapel Hill, North Carolina (H.X.,
K.L.R.B.); and Pharmacogenetics Section, Laboratory of Reproductive and
Developmental Toxicology, National Institute of Environmental Health
Sciences, National Institutes of Health, Research Triangle Park, North
Carolina (K.Y., M.N.)
Phenobarbital (PB) induces the hepatic organic anion
transporter, Mrp3. The present study tested the hypothesis that Mrp3 induction by PB is mediated by the constitutive androstane receptor (CAR). PB induction of Mrp3 and CYP2B was examined in lean and obese
Zucker rats, male and female Wistar Kyoto (WKY) rats, HepG2 and mouse
CAR-expressing HepG2 (g2car-3) cells; HepG2 and g2car-3 cells also were
treated with 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP). In
obese Zucker rat livers, total and nuclear CAR levels were markedly
lower compared with lean rat livers, which correlated with the poor
induction of CYP2B1/2 by PB in obese Zucker rats. Mrp3 induction by PB
also was impaired in obese Zucker rat livers. Induction of Mrp3 by PB
was similar in male and female WKY rat livers, despite the fact that
CAR protein levels were significantly lower in female relative to male
WKY rat livers. MRP3 levels in both HepG2 and g2car-3 cells were
induced to a similar extent in the two cell lines by PB but not by
TCPOBOP. In contrast, CYP2B6 levels were measurable and induced by
TCPOBOP only in g2car-3 cells. In conclusion, data from WKY rats and
HepG2 cells suggest that CAR does not play a key role in PB induction
of Mrp3. Impaired induction of Mrp3 by PB in obese Zucker rats is not
due solely to CAR deficiency. Interestingly, differences in the
constitutive levels of Mrp3 were observed between obese and lean Zucker
rats and between male and female WKY rats.
This article has been cited by other articles:
![]() |
W. Chen, S.-Y. Cai, S. Xu, L. A. Denson, C. J. Soroka, and J. L. Boyer Nuclear receptors RXR{alpha}:RAR{alpha} are repressors for human MRP3 expression Am J Physiol Gastrointest Liver Physiol, May 1, 2007; 292(5): G1221 - G1227. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kawase, Y. Tsunokuni, and M. Iwaki Effects of Alterations in CAR on Bilirubin Detoxification in Mouse Collagen-Induced Arthritis Drug Metab. Dispos., February 1, 2007; 35(2): 256 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Jigorel, M. Le Vee, C. Boursier-Neyret, Y. Parmentier, and O. Fardel Differential Regulation of Sinusoidal and Canalicular Hepatic Drug Transporter Expression by Xenobiotics Activating Drug-Sensing Receptors in Primary Human Hepatocytes Drug Metab. Dispos., October 1, 2006; 34(10): 1756 - 1763. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Ding, K. Lichti, I. Kim, F. J. Gonzalez, and J. L. Staudinger Regulation of Constitutive Androstane Receptor and Its Target Genes by Fasting, cAMP, Hepatocyte Nuclear Factor {alpha}, and the Coactivator Peroxisome Proliferator-activated Receptor {gamma} Coactivator-1{alpha} J. Biol. Chem., September 8, 2006; 281(36): 26540 - 26551. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Slitt, N. J. Cherrington, C. D. Fisher, M. Negishi, and C. D. Klaassen INDUCTION OF GENES FOR METABOLISM AND TRANSPORT BY TRANS-STILBENE OXIDE IN LIVERS OF SPRAGUE-DAWLEY AND WISTAR-KYOTO RATS Drug Metab. Dispos., July 1, 2006; 34(7): 1190 - 1197. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Slitt, N. J. Cherrington, M. Z. Dieter, L. M. Aleksunes, G. L. Scheffer, W. Huang, D. D. Moore, and C. D. Klaassen trans-Stilbene Oxide Induces Expression of Genes Involved in Metabolism and Transport in Mouse Liver via CAR and Nrf2 Transcription Factors Mol. Pharmacol., May 1, 2006; 69(5): 1554 - 1563. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Maher, X. Cheng, A. L. Slitt, M. Z. Dieter, and C. D. Klaassen INDUCTION OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN FAMILY OF TRANSPORTERS BY CHEMICAL ACTIVATORS OF RECEPTOR-MEDIATED PATHWAYS IN MOUSE LIVER Drug Metab. Dispos., July 1, 2005; 33(7): 956 - 962. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Belinsky, P. A. Dawson, I. Shchaveleva, L. J. Bain, R. Wang, V. Ling, Z.-S. Chen, A. Grinberg, H. Westphal, A. Klein-Szanto, et al. Analysis of the In Vivo Functions of Mrp3 Mol. Pharmacol., July 1, 2005; 68(1): 160 - 168. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Qatanani, J. Zhang, and D. D. Moore Role of the Constitutive Androstane Receptor in Xenobiotic-Induced Thyroid Hormone Metabolism Endocrinology, March 1, 2005; 146(3): 995 - 1002. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Rencurel, A. Stenhouse, S. A. Hawley, T. Friedberg, D. G. Hardie, C. Sutherland, and C. R. Wolf AMP-activated Protein Kinase Mediates Phenobarbital Induction of CYP2B Gene Expression in Hepatocytes and a Newly Derived Human Hepatoma Cell Line J. Biol. Chem., February 11, 2005; 280(6): 4367 - 4373. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. St-Pierre, T. Stallmach, A. Freimoser Grundschober, J.-F. Dufour, M. A. Serrano, J. J. G. Marin, Y. Sugiyama, and P. J. Meier Temporal expression profiles of organic anion transport proteins in placenta and fetal liver of the rat Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2004; 287(6): R1505 - R1516. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, W. Huang, M. Qatanani, R. M. Evans, and D. D. Moore The Constitutive Androstane Receptor and Pregnane X Receptor Function Coordinately to Prevent Bile Acid-induced Hepatotoxicity J. Biol. Chem., November 19, 2004; 279(47): 49517 - 49522. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Swales and M. Negishi CAR, Driving into the Future Mol. Endocrinol., July 1, 2004; 18(7): 1589 - 1598. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Assem, E. G. Schuetz, M. Leggas, D. Sun, K. Yasuda, G. Reid, N. Zelcer, M. Adachi, S. Strom, R. M. Evans, et al. Interactions between Hepatic Mrp4 and Sult2a as Revealed by the Constitutive Androstane Receptor and Mrp4 Knockout Mice J. Biol. Chem., May 21, 2004; 279(21): 22250 - 22257. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Handschin and U. A. Meyer Induction of Drug Metabolism: The Role of Nuclear Receptors Pharmacol. Rev., December 1, 2003; 55(4): 649 - 673. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Cherrington, A. L. Slitt, J. M. Maher, X.-X. Zhang, J. Zhang, W. Huang, Y.-J. Y. Wan, D. D. Moore, and C. D. Klaassen INDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 (MRP3) IN VIVO IS INDEPENDENT OF CONSTITUTIVE ANDROSTANE RECEPTOR Drug Metab. Dispos., November 1, 2003; 31(11): 1315 - 1319. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Slitt, N. J. Cherrington, J. M. Maher, and C. D. Klaassen INDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 IN RAT LIVER IS ASSOCIATED WITH ALTERED VECTORIAL EXCRETION OF ACETAMINOPHEN METABOLITES Drug Metab. Dispos., September 1, 2003; 31(9): 1176 - 1186. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Auerbach, R. Ramsden, M. A. Stoner, C. Verlinde, C. Hassett, and C. J. Omiecinski Alternatively spliced isoforms of the human constitutive androstane receptor Nucleic Acids Res., June 15, 2003; 31(12): 3194 - 3207. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wang, D. P. Hartley, S. L. Ciccotto, S. H. Vincent, R. B. Franklin, and M.-S. Kim INDUCTION OF HEPATIC PHASE II DRUG-METABOLIZING ENZYMES BY 1,7-PHENANTHROLINE IN RATS IS ACCOMPANIED BY INDUCTION OF MRP3 Drug Metab. Dispos., June 1, 2003; 31(6): 773 - 775. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Staudinger, A. Madan, K. M. Carol, and A. Parkinson Regulation of Drug Transporter Gene Expression by Nuclear Receptors Drug Metab. Dispos., May 1, 2003; 31(5): 523 - 527. [Abstract] [Full Text] [PDF] |
||||